Arcadia Biosciences
RKDA
8 hedge funds and large institutions have $210K invested in Arcadia Biosciences in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
27% less funds holding
Funds holding: 11 → 8 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
88% less capital invested
Capital invested by funds: $1.79M → $210K (-$1.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$112K |
| 2 |
VF
Virtu Financial
New York
|
+$23.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.15K |
| 4 |
Goldman Sachs
New York
|
+$5.63K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$1.63M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$19K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $152K | +$112K | +516 | +295% |
|
|
VF
2
Virtu Financial
New York
| $28K | +$23.6K | +109 | +574% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $14K | +$7.15K | +33 | +100% |
|
|
4
Goldman Sachs
New York
| $6K | +$5.63K | +26 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$3.25K | +15 | +167% |
|
6
Northern Trust
Chicago,
Illinois
| $4K | – | – | – |
|
7
BlackRock
New York
| $1K | – | – | – |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3 | – | – | – |
|
|
WRF
9
Waddell & Reed Financial
Overland Park,
Kansas
| – | -$1.63M | -4,736 | Closed |
|
|
10
Vanguard Group
Malvern,
Pennsylvania
| – | -$41K | -120 | Closed |
|
|
11
Creative Planning
Overland Park,
Kansas
| – | -$19K | -56 | Closed |
|
|
BCM
12
Bridgeway Capital Management
Houston,
Texas
| – | -$17K | -50 | Closed |
|
|
SWM
13
SeaCrest Wealth Management
Purchase,
New York
| – | +$217 | +1 | New |
|
RKDA Hedge Fund Activity: Q4 2017 in Review
8 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2017, worth a combined $210K — down 88% from $1.79M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RKDA and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $112K. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $1.63M sold.
- 8 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2017, down from 11 in Q3 2017.
- Funds reported $210K of Arcadia Biosciences stock for Q4 2017, down 88% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q4 2017 and 5 closed out, a net change of -3 holders.
- The largest Arcadia Biosciences buyer in Q4 2017 was Renaissance Technologies, an estimated $112K added.
- The largest Arcadia Biosciences seller in Q4 2017 was Waddell & Reed Financial, an estimated $1.63M sold.
Based on aggregated 13F filings for Q4 2017.